AI-generated summary
The authors compared the 308-nm excimer laser with the 308-nm excimer lamp in a randomized self-control trial of 14 vitiligo patients, treating paired symmetrical lesions with each device for 20 sessions. The authors report that the two treatments produced similar repigmentation and conclude they had similar efficacy.
- Participants
- 14
- Who or what was studied
- Fourteen vitiligo patients with 48 symmetrical lesions
- Wavelengths
- 308, 308 nm
- Limits stated in the abstract
- The abstract describes a small sample of 14 subjects and does not report a control group or statistical measures of the repigmentation comparison.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Phototherapy, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.